News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mediatech, Inc. And GlobalStem, Inc. Form Strategic Alliance



11/7/2006 12:46:52 PM

HERNDON, Va., Nov. 7 /PRNewswire/ -- Mediatech, Inc., makers of the brand cellgro(R), and GlobalStem, Inc. have recently formed a strategic alliance to develop, manufacture, validate, and distribute Embryonic Stem Cell-qualified growth media and supplements. Each company's core competencies and strengths, when combined, create a mutually beneficial synergy. Mediatech contributes over 20 years of cGMP experience in the manufacture of sterile solutions while GlobalStem brings a wealth of knowledge and research in the field of embryonic stem cells (ESC).

Pluripotent ES cells are capable of self-renewal while maintaining the malleability to differentiate into other major cell types in the body. This gives promise to the technology of cell replacement therapies aimed at remedying disease such as diabetes, Parkinson's, spinal cord injuries and stroke. Human ES cells also provide an excellent model for the study of normal human development. Despite the rapid progress in recent years, there still exists an unmet need among stem cell researchers for fully characterized stem cell lines, validated feeder cells, qualified reagents and characterization tools. The alliance formed between Mediatech and GlobalStem hopes to bridge this gap and advance such a promising aspect of medicine.

About Mediatech, Inc.

Mediatech, Inc. is a leading manufacturer and supplier of cell culture and molecular biology reagents to biopharmaceutical, academic and government research facilities, as well as biotechnology companies. Mediatech prides itself on unprecedented levels of quality and rigid release specifications for products. In addition to following current Good Manufacturing Processes (cGMP) and complying with FDA Guidelines for Class I Medical Devices, Mediatech is certified under ISO 13485:2003 and compliant with ISO 17025:2001. Most recently, Mediatech was licensed as a drug establishment for the production and distribution of WFI water. Mediatech's facility design and Quality Assurance Systems guarantee low endotoxin levels for both liquid and powdered products and meets the most rigid Sterility Assurance Levels for liquid products. All cellgro(R) basal media and salt solutions must test negative for mycoplasma prior to release. For more information visit http://www.cellgro.com.

About GlobalStem, Inc.

Founded in March 2006, GlobalStem, Inc. boasts a highly experienced, well- trained staff of stem cell experts. Their mission is to accelerate the advance of stem cell research through the development and distribution of quality cell lines, products, services, and technical support. GlobalStem aims to provide ESC-validated growth media, sera, supplements, growth factors, and assay kits, in addition to being a comprehensive resource center of cell lines, technical information, and technology platforms for the universal stem cell research community. GlobalStem is involved in the acquisition and derivation of stem cell lines, the manufacturing, banking, and distribution of these cells, and development of new research tools and for stem cell research. For more information visit http://www.globalstem.com.

CONTACT: Lauren Supko, Marketing Associate of Mediatech, Inc., +1-703-471-5955, or lsupko@cellgro.com

Mediatech, Inc.

CONTACT: Lauren Supko, Marketing Associate of Mediatech, Inc.,+1-703-471-5955, or lsupko@cellgro.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES